Our clinical case digest brings together the vast and varied peer discussions of our Myopia Profile Facebook group into valuable, enduring content with the addition of key learnings, relevant research and engaging graphics. Seeing the research put into practice, in real patient cases, will help you elevate your myopia management knowledge and confidence to higher levels.
Getting the most out of Myopia Profile Welcome to the world’s largest and most popular multi-platform digital suite dedicated to myopia management! Perhaps you’re new to the Myopia Profile website,… The HOYA MiYOSMART was the first of the new generation of myopia control spectacle lenses, with evidence for slowing myopia progression by at least half. Learn more about efficacy, the lens design, visual outcomes and more. This prospective observational study found that DIMS spectacle lenses, atropine 0.01% and the combination of the two all showed robust efficacy for myopia control in European children. The combination treatment showed slightly better refractive control than the mono-therapies, but axial length growth was similar in all treatment groups. The MiSight 1 day clinical trial is the longest-running soft contact lens study among children, and is now reporting seven-year data. With questions explored including efficacy, cross over from control group to treatment and discontinuation, here’s some of what we’ve learnt along the way. Spectacle lenses for myopia control provide a clear central zone and a ‘treatment’ area for myopic defocus. This study found that atropine 0.01% and glare situations had minimal impacts on visual performance when adults wore the DIMS spectacle lens. This indicates likely tolerance of the combination in children. In this Q&A Interview, Optometrist Elizabeth Lumb reflects on the evolution of myopia management in the past five years through two ‘lenses’: as CooperVision’s Director of Global Professional Affairs, Myopia Management, and through the very personal experience of her now 12-year-old niece, Maddy. This retrospective study from Ireland found that despite recent increases in practitioners fitting myopia control contact lenses in Ireland, more than 60% of children were still managed with single vision correction only. Improving the prescribing rates of evidence-based myopia control treatments will ensure progressing myopes are less likely to miss appropriate intervention opportunities. This study found the risk of microbial keratitis for children fitted with contact lenses for myopia control was less than the risk of visual impairment from myopia progression to over 3D or axial lengths exceeding 26mm. If worn throughout childhood, the extra benefits of myopia control contact lenses outweigh the risks of infection, especially if the lenses are daily disposable. This case describes a teenager with a low refractive error but a surprisingly long axial length. Should we monitor or actively manage their myopia? In this case, axial length tells a different story than other factors in identifying the long-term risks of myopia for the patient. Orthokeratology fitting to children is increasing in frequency worldwide, due to its volume of evidence for myopia control. Learn what data inputs are needed and how to best use your topographer for accurate ortho-k lens design. This review investigated 18 years of practice data for the predictability, efficacy and safety of long-term ortho-k wear. The results showed that for at least one year’s wear, there was good efficacy and predictability of target refraction. Although corneal staining was common, serious adverse effects were found to be rare, particularly for children.How to Use Myopia Profile
Understanding the HOYA MiYOSMART spectacle lens performance
Combining DIMS spectacle lenses with atropine 0.01% in European children
Five things we know about MiSight 1 day
Is visual performance affected when combining atropine 0.01% with DIMS spectacle lenses?
Driving change in myopia management – Q&A with Elizabeth Lumb
How has Ireland embraced the use of myopia control contact lenses?
What is the risk-to-benefit balance for myopia control contact lenses in children?
A low myope with long axial length
What topography data do I need to fit orthokeratology lenses?
How well does orthokeratology work over long periods of time?
